Kezar Life Sciences Inc
(NASDAQ: KZR)

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 19, 2015 and is headquartered in South San Francisco, CA.

6.120 -

-0.030 (-0.49%)
Range 6.110 - 6.160   (0.82%)
Open 6.130
Previous Close 6.150
Bid Price 6.120
Bid Volume 15
Ask Price 6.240
Ask Volume 100
Volume 6,801
Value 29,170
Remark -
Delayed prices. Updated at 30 Jan 2026 01:19.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis